Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Novel non-sulfonamide 5-HT 6 receptor partial inverse agonist in a group of imidazo[4,5- b ]pyridines with cognition enhancing properties
David Vanda, Miroslav Soural, Vittorio Canale, et al.
European Journal of Medicinal Chemistry (2017) Vol. 144, pp. 716-729
Closed Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

The role of 5 HT6-receptor antagonists in Alzheimer’s disease: an update
Rita Khoury, Noam Grysman, Jake Gold, et al.
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 6, pp. 523-533
Closed Access | Times Cited: 98
First-in-Class Selenium-Containing Potent Serotonin Receptor 5-HT6 Agents with a Beneficial Neuroprotective Profile against Alzheimer’s Disease
Patryk Pyka, Wawrzyniec Haberek, Małgorzata Więcek, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1580-1610
Open Access | Times Cited: 12
Imidazopyridine-based selective and multifunctional ligands of biological targets associated with psychiatric and neurodegenerative diseases
David Vanda, Paweł Zajdel, Miroslav Soural
European Journal of Medicinal Chemistry (2019) Vol. 181, pp. 111569-111569
Closed Access | Times Cited: 75
Constitutive activity of 5-HT receptors: Factual analysis
Philippe De Deurwaerdère, Rahul Bharatiya, Abdeslam Chagraoui, et al.
Neuropharmacology (2020) Vol. 168, pp. 107967-107967
Open Access | Times Cited: 51
The 1,3,5-Triazine Derivatives as Innovative Chemical Family of 5-HT6 Serotonin Receptor Agents with Therapeutic Perspectives for Cognitive Impairment
Gniewomir Latacz, Annamaria Lubelska, Magdalena Jastrzębska‐Więsek, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 14, pp. 3420-3420
Open Access | Times Cited: 50
The 5-HT6 receptor interactome: New insight in receptor signaling and its impact on brain physiology and pathologies
Séverine Chaumont‐Dubel, Vincent Dupuy, Joël Bockaert, et al.
Neuropharmacology (2019) Vol. 172, pp. 107839-107839
Open Access | Times Cited: 47
An Overview of Piperazine Scaffold as Promising Nucleus for Different Therapeutic Targets
Anjali Sharma, Sharad Wakode, Faizana Fayaz, et al.
Current Pharmaceutical Design (2020) Vol. 26, Iss. 35, pp. 4373-4385
Closed Access | Times Cited: 41
Imidazopyridine, a promising scaffold with potential medicinal applications and structural activity relationship (SAR): recent advances
Samima Khatun, Abhinav Singh, Ghulam Nabi Bader, et al.
Journal of Biomolecular Structure and Dynamics (2021) Vol. 40, Iss. 24, pp. 14279-14302
Closed Access | Times Cited: 36
Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
ARMAN YURISALDI SALEH, Dwi Arwandi Yogi Saputra, Riezky Valentina, et al.
F1000Research (2025) Vol. 14, pp. 275-275
Open Access
Virtual screening-driven discovery of dual 5-HT6/5-HT2A receptor ligands with pro-cognitive properties
Jakub Staroń, Rafał Kurczab, Dawid Warszycki, et al.
European Journal of Medicinal Chemistry (2019) Vol. 185, pp. 111857-111857
Open Access | Times Cited: 35
mTOR activation by constitutively active serotonin6 receptors as new paradigm in neuropathic pain and its treatment
Pierre-Yves Martin, Stéphane Doly, Al Mahdy Hamieh, et al.
Progress in Neurobiology (2020) Vol. 193, pp. 101846-101846
Open Access | Times Cited: 28
Superiority of the Triple-Acting 5-HT6R/5-HT3R Antagonist and MAO-B Reversible Inhibitor PZ-1922 over 5-HT6R Antagonist Intepirdine in Alleviation of Cognitive Deficits in Rats
Katarzyna Grychowska, Uriel López-Sánchez, Mathieu Vitalis, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 21, pp. 14928-14947
Open Access | Times Cited: 10
Dual 5-HT6 and D3 Receptor Antagonists in a Group of 1H-Pyrrolo[3,2-c]quinolines with Neuroprotective and Procognitive Activity
Katarzyna Grychowska, Séverine Chaumont‐Dubel, Rafał Kurczab, et al.
ACS Chemical Neuroscience (2019) Vol. 10, Iss. 7, pp. 3183-3196
Open Access | Times Cited: 29
Synthesis and computer-aided SAR studies for derivatives of phenoxyalkyl-1,3,5-triazine as the new potent ligands for serotonin receptors 5-HT6
Wesam Ali, Małgorzata Więcek, Dorota Łażewska, et al.
European Journal of Medicinal Chemistry (2019) Vol. 178, pp. 740-751
Closed Access | Times Cited: 24
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors
Maria Giulia Nizi, Jenny Desantis, Yoshio Nakatani, et al.
European Journal of Medicinal Chemistry (2020) Vol. 201, pp. 112420-112420
Closed Access | Times Cited: 23
A dual-acting 5-HT6 receptor inverse agonist/MAO-B inhibitor displays glioprotective and pro-cognitive properties
Vittorio Canale, Katarzyna Grychowska, Rafał Kurczab, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112765-112765
Open Access | Times Cited: 22
Imidazopyridine-Based 5-HT6 Receptor Neutral Antagonists: Impact of N1-Benzyl and N1-Phenylsulfonyl Fragments on Different Receptor Conformational States
David Vanda, Vittorio Canale, Séverine Chaumont‐Dubel, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 2, pp. 1180-1196
Closed Access | Times Cited: 20
5-HT6 receptor neutral antagonists protect astrocytes: A lesson from 2-phenylpyrrole derivatives
Marcin Drop, Paulina Koczurkiewicz, Ophélie Bento, et al.
European Journal of Medicinal Chemistry (2024) Vol. 275, pp. 116615-116615
Open Access | Times Cited: 2
Structure-Based Design and Optimization of FPPQ, a Dual-Acting 5-HT3 and 5-HT6 Receptor Antagonist with Antipsychotic and Procognitive Properties
Paweł Zajdel, Katarzyna Grychowska, Szczepan Mogilski, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13279-13298
Open Access | Times Cited: 17
1-(Arylsulfonyl-isoindol-2-yl)piperazines as 5-HT6R Antagonists: Mechanochemical Synthesis, In Vitro Pharmacological Properties and Glioprotective Activity
Vittorio Canale, Wojciech Trybała, Séverine Chaumont‐Dubel, et al.
Biomolecules (2022) Vol. 13, Iss. 1, pp. 12-12
Open Access | Times Cited: 12
Current development in sulfonamide derivatives to enable CNS-drug discovery
Klaudia Blicharz-Futera, Michał Kamiński, Katarzyna Grychowska, et al.
Bioorganic Chemistry (2024) Vol. 156, pp. 108076-108076
Closed Access | Times Cited: 2
Spatiotemporal dynamics of 5-HT6 receptor ciliary localization during mouse brain development
Vincent Dupuy, Matthieu Prieur, Anne Pizzoccaro, et al.
Neurobiology of Disease (2022) Vol. 176, pp. 105949-105949
Open Access | Times Cited: 10
Pyrroloquinoline scaffold-based 5-HT6R ligands: Synthesis, quantum chemical and molecular dynamic studies, and influence of nitrogen atom position in the scaffold on affinity
Katarzyna Grychowska, Rafał Kurczab, Paweł Śliwa, et al.
Bioorganic & Medicinal Chemistry (2018) Vol. 26, Iss. 12, pp. 3588-3595
Closed Access | Times Cited: 16
The Antagonism of 5-HT6 Receptor Attenuates Current-Induced Spikes and Improves Long-Term Potentiation via the Regulation of M-Currents in a Pilocarpine-Induced Epilepsy Model
Chaofeng Zhu, Rong Lin, Changyun Liu, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 13
Desformylflustrabromine, a positive allosteric modulator of α4β2-containing nicotinic acetylcholine receptors, enhances cognition in rats
Agnieszka Nikiforuk, Ewa Litwa, Martyna Krawczyk, et al.
Pharmacological Reports (2020) Vol. 72, Iss. 3, pp. 589-599
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top